(Q33182007)

23 July 2017

In vivo efficacy of the new ketolide telithromycin (HMR 3647) in murine infection models (English)

1 reference

23 July 2017

A Bonnefoy

1

1 reference

23 July 2017

M Guitton

2

1 reference

23 July 2017

C Delachaume

3

1 reference

23 July 2017

P Le Priol

4

1 reference

23 July 2017

A M Girard

5

1 reference

23 July 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

Antimicrobial Agents and Chemotherapy

23 July 2017

1 reference

23 July 2017

45

1 reference

23 July 2017

6

1 reference

23 July 2017

1688-1692

1 reference

Patterns of macrolide resistance determinants among community-acquired Streptococcus pneumoniae isolates over a 5-year period of decreased macrolide susceptibility rates.

23 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90532

The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90532

Ketolide treatment of Haemophilus influenzae experimental pneumonia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90532

Activity of HMR 3647 compared to those of five agents against Haemophilus influenzae and moraxella catarrhalis by MIC determination and time-kill assay

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90532

In vitro activities of the ketolide HMR 3647 against recent gram-positive clinical isolates and Haemophilus influenzae

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90532

Antibacterial activity of rokitamycin against fresh clinical isolates

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90532

Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program

21 June 2018

1 reference

12 December 2020

Pharmacodynamic properties of HMR 3647, a novel ketolide, on respiratory pathogens, enterococci and Bacteroides fragilis demonstrated by studies of time-kill kinetics and postantibiotic effect

1 reference

12 December 2020

Comparative antimicrobial activity and kill-curve investigations of novel ketolide antimicrobial agents (HMR 3004 and HMR 3647) tested against Haemophilus influenzae and Moraxella catarrhalis strains

1 reference

12 December 2020

In-vitro activity of HMR 3647 against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and beta-haemolytic streptococci

1 reference

12 December 2020

A simplified method of evaluating dose-effect experiments

1 reference

12 December 2020

Pneumococcal macrolide resistance-not a myth

1 reference

12 December 2020

10.1128/AAC.45.6.1688-1692.2001

Identifiers

DOI

1 reference

23 July 2017

1 reference

23 July 2017

1 reference